PTPN11
Universal Cellular Machinery · Dephosphorylation & Phosphatase Regulation
How can PTPN11 affect development through cell signaling?
PTPN11 encodes SHP-2, a regulator of the RAS/MAPK pathway. This pathway influences growth, specialization, and movement of cells as tissues form and function.
- Common Gene Name
- protein tyrosine phosphatase non-receptor type 11
- NCBI Gene ID
- 5781
- Chromosome
- 12
Clinical Evidence Status
Actionability report availableEstablished disease relationshipTumor or drug-label biomarker context
These labels describe available evidence about a gene. They do not classify your variant or recommend a treatment.
Answer Sources
Explore supporting evidence (9 records)
| Condition or drug | Evidence | Grade / status | Context | Source |
|---|---|---|---|---|
| Noonan syndrome | ClinGen gene-disease validity | Definitive | Autosomal dominant | View source 2018-07-24 |
| Costello syndrome | ClinGen gene-disease validity | Disputed | Autosomal dominant | View source 2018-05-31 |
| cardiofaciocutaneous syndrome | ClinGen gene-disease validity | Disputed | Autosomal dominant | View source 2018-05-30 |
| Noonan syndrome with multiple lentigines | ClinGen gene-disease validity | Definitive | Autosomal dominant | View source 2018-07-25 |
| Noonan syndrome | ClinGen clinical actionability | Scored report; not a validity grade | Adult | View source 2020-04-22 |
| Noonan Syndrome with Multiple Lentigines | ClinGen clinical actionability | Scored report; not a validity grade | Adult | View source 2021-06-07 |
| Noonan syndrome | ClinGen clinical actionability | Scored report; not a validity grade | Pediatric | View source 2022-02-09 |
| Noonan Syndrome with Multiple Lentigines | ClinGen clinical actionability | Scored report; not a validity grade | Pediatric | View source 2022-02-09 |
| Azacitidine (2) | FDA labeling biomarker | Label mentions biomarker; actionability not inferred | Oncology | View source |
Source snapshot: 2026-09-09. Consumer text updated: 2026-09-10. Source dates describe the cited records, not a new clinical review.
← Back to Universal Cellular Machinery